Prognostic significance and extra-hypothalamus dysfunction of hyponatremia in anti-leucine-rich glioma-inactivated protein 1 encephalitis

[1]  J. Britton,et al.  Clinical Course and Features of Seizures Associated With LGI1-Antibody Encephalitis , 2021, Neurology.

[2]  E. Mignot,et al.  Clinical and Prognostic Value of Immunogenetic Characteristics in Anti-LGI1 Encephalitis , 2021, Neurology: Neuroimmunology & Neuroinflammation.

[3]  A. Venkatesan,et al.  Autoimmune encephalitis: proposed recommendations for symptomatic and long-term management , 2021, Journal of Neurology, Neurosurgery, and Psychiatry.

[4]  E. Guedj,et al.  Brain 18F-FDG PET for the diagnosis of autoimmune encephalitis: a systematic review and a meta-analysis , 2021, European Journal of Nuclear Medicine and Molecular Imaging.

[5]  Ran-Ran Zhang,et al.  Clinical Features and Long-Term Outcomes of Anti-Leucine-Rich Glioma-Inactivated 1 Encephalitis: A Multi-Center Study , 2021, Neuropsychiatric disease and treatment.

[6]  D. Morland,et al.  18F-FDG PET/CT in Anti-Leucine-Rich Glioma-Inactivated 1 Antibody Encephalitis: Typical Pattern and Follow-up. , 2020, Clinical nuclear medicine.

[7]  G. Biolo,et al.  Hypernatremia and moderate-to-severe hyponatremia are independent predictors of mortality in septic patients at emergency department presentation: A sub-group analysis of the need-speed trial. , 2020, European journal of internal medicine.

[8]  Jingping Shi,et al.  Clinical Characteristics of Cognitive Impairment and 1-Year Outcome in Patients With Anti-LGI1 Antibody Encephalitis , 2020, Frontiers in Neurology.

[9]  Yaou Liu,et al.  The Clinical Value of 18F-FDG-PET in Autoimmune Encephalitis Associated With LGI1 Antibody , 2020, Frontiers in Neurology.

[10]  Cynthia M. Cooper,et al.  Case 15-2020: A 79-Year-Old Man with Hyponatremia and Involuntary Movements of the Arm and Face. , 2020, New England Journal of Medicine.

[11]  R. Sánchez-Valle,et al.  Telemedicine assessment of long-term cognitive and functional status in anti-leucine-rich, glioma-inactivated 1 encephalitis , 2019, Neurology: Neuroimmunology & Neuroinflammation.

[12]  L. Cui,et al.  Anti-NMDAR encephalitis , 2019, Neurology: Neuroimmunology & Neuroinflammation.

[13]  C. Bien,et al.  Selective Limbic Blood–Brain Barrier Breakdown in a Feline Model of Limbic Encephalitis with LGI1 Antibodies , 2017, Front. Immunol..

[14]  J. Britton,et al.  Expanded phenotypes and outcomes among 256 LGI1/CASPR2‐IgG–positive patients , 2017, Annals of neurology.

[15]  M. Titulaer,et al.  Autoimmune encephalitis with anti-leucine-rich glioma-inactivated 1 or anti-contactin-associated protein-like 2 antibodies (formerly called voltage-gated potassium channel-complex antibodies) , 2017, Current opinion in neurology.

[16]  E. Sánchez,et al.  Anti-LGI1 encephalitis , 2016, Neurology.

[17]  S. Hesse,et al.  Role of 18F-FDG-PET imaging in the diagnosis of autoimmune encephalitis , 2016, The Lancet Neurology.

[18]  J. Dalmau,et al.  Anti-LGI1–associated cognitive impairment , 2016, Neurology.

[19]  A. Venkatesan,et al.  A clinical approach to diagnosis of autoimmune encephalitis , 2016, The Lancet Neurology.

[20]  M. Baulac,et al.  Motor cortex and hippocampus are the two main cortical targets in LGI1-antibody encephalitis. , 2016, Brain : a journal of neurology.

[21]  Z. Illés,et al.  Natural course of LGI1 encephalitis: 3–5years of follow-up without immunotherapy , 2014, Journal of the Neurological Sciences.

[22]  K. Chu,et al.  VGKC-complex/LGI1-antibody encephalitis: Clinical manifestations and response to immunotherapy , 2013, Journal of Neuroimmunology.

[23]  C. Klein,et al.  Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping. , 2013, JAMA neurology.

[24]  A. Vincent,et al.  Morvan syndrome: Clinical and serological observations in 29 cases , 2012, Annals of neurology.

[25]  B. Cheeran,et al.  Immunotherapy-responsive chorea as the presenting feature of LGI1-antibody encephalitis , 2012, Neurology.

[26]  J. Schott,et al.  Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis , 2011, Annals of neurology.

[27]  R. Balice-Gordon,et al.  Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series , 2010, The Lancet Neurology.